Israel’s BrainStorm Receives $2.1 Million Grant to Support Development of Stem-Cell Therapy NurOwn to Treat ALS – ALS News Today
ALS News Today |
Israel's BrainStorm Receives $2.1 Million Grant to Support Development of Stem–Cell Therapy NurOwn to Treat ALS
ALS News Today NurOwn was developed by Tel Aviv University professors Dani Offen and the late Eldad Melamed. NurOwn builds on research developing mesenchymal stem cells (MSCs) as a treatment for human diseases. MSCs are multipotent precursor cells that exist in … |
